Detalhe da pesquisa
1.
Mutational activation of BRAF confers sensitivity to transforming growth factor beta inhibitors in human cancer cells.
Oncotarget
; 7(50): 81995-82012, 2016 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-27835901